Equitec Specialists’s DNA X Inc SONM Stock Holding History

Equitec Specialists’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-167	Closed	-$1.09M	–	147
2019 Q4	$1.09M	Buy	167 +166	+16,600%	+$819K	0.3%	52
2019 Q3	$7K	Buy	+1	New	+$15.3K	﹤0.01%	138

Other funds holding SONM

Nokomis Capital Dallas, Texas $290M AUM 55.12% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return

Equitec Specialists's SONM Position: Q1 2020 in Review

Equitec Specialists sold out of DNA X Inc (SONM) in Q1 2020, closing a stake of 167 shares — an estimated $1.09M sold.

Equitec Specialists first reported a position in SONM in Q3 2019 and held it in 2 quarters. The position peaked at $1.09M in Q4 2019. 37 funds tracked by Wall St. Rank hold SONM as of Q1 2020.

Equitec Specialists reported no remaining DNA X Inc position as of Q1 2020 after selling out during the quarter.
Equitec Specialists sold 167 DNA X Inc shares in Q1 2020, an estimated $1.09M.
Equitec Specialists first reported a position in DNA X Inc in Q3 2019 and held it in 2 quarters.
Equitec Specialists's DNA X Inc position peaked at $1.09M in Q4 2019.
37 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2020.

Based on Equitec Specialists's 13F filing for Q1 2020, filed 23 Apr 2020.